Latest News - REBECCA

REBECCA monitoring of prostate cancer patients

At Stavanger University Hospital (SUH) in Norway, efforts are focused on monitoring the quality of life of cancer patients affected by cancer-related fatigue (CRF) after primary treatment. In traditional clinical trials, patients’ quality of life and CRF status are typically assessed using questi...

An intervention study based on real-world data to improve quality of life after breast cancer treatment

Many breast cancer patients suffer from cancer-related fatigue (CRF) during and after primary treatment. Up to one-third experience chronic CRF, which can persist for as long as 10 years post-treatment. Fatigue significantly impacts patients’ quality of life, often hindering daily functioning. Th...

Characterisation of quality of life and late side-effects in breast cancer patients 

The observational REBECCA-CRF study (also called the REBECCA-1 study), conducted at Stavanger University Hospital (SUH) in Norway, aims to expand knowledge about the quality of life of patients affected by cancer-related fatigue (CRF) during and after cancer treatment. CRF is one of the most comm...

Voices of recovery: A Breast Cancer survivor’s journey with the REBECCA project

As the REBECCA project continues to make strides in enhancing the care and quality of life for breast cancer patients through real-world data, we are excited to share insights from a recent interview with a breast cancer survivor who participated in one of our studies. But before diving into the...

The Potential of Real-World Data from Breast Cancer Patients to Compare the Quality of Follow-Up in Chemotherapy or Radiotherapy Treatment

Real-world data, collected through devices and mobile applications, constitutes a valuable source of information about patients' behaviours and routines. This information allows for evaluating the impact of treatments on their quality of life, making more informed decisions to mitigate side effec...

Analysis of Lifestyle Data of Breast Cancer Patients to Assess Bone Health

The exploratory study on bone health REBECCA-OST, carried out in Spain INCLIVA Biomedical Research Institute, focuses on understanding the effects of adjuvant endocrine therapy with aromatase inhibitors on the bone health of breast cancer patients to improve their treatments. Although this treatm...

Incorporating Lifestyle Data of Breast Cancer Patients to Assess Bone Health and Improve Treatment

Breast cancer patients are at increased risk of fractures due to osteoporosis resulting from estrogen reduction caused by treatments, which significantly lowers Bone Mineral Density (BMD). To counteract it, the integration of non-pharmacological measures such as weight-bearing exercises and calci...

Advancements in the REBECCA system: Empowering personalised breast cancer care through real-world data

During the plenary meeting in Athens in February 2024, Netcompany Intrasoft presented the newest updates to the consortium on the REBECCA system. Today, we would like to present the REBECCA application in more depth and discuss recent achievements. Real-World Data and the REBECCA app First, we ne...

Insights from the REBECCA Plenary Gathering in Athens, Greece

Stimulating discussions, enlightening feedback, and active participation characterised the third REBECCA plenary meeting, taking place on the 22nd and 23rd 2024 of February in the city of Athens. The two-day agenda brought together 12 partners from seven European countries, both online and on-sit...

INCLIVA and the Clinical Hospital of València held the second Meeting with breast cancer patient associations to showcase the latest advances in research

Researchers emphasise the importance of adopting healthy lifestyle habits regarding nutrition and physical exercise. València, February 6, 2024. The INCLIVA Health Research Institute, together with the Breast Cancer Unit of the University Clinical Hospital of València, organised a meeting w...